ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
SCH 503034 Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659)(COMPLETED)

This study has been completed.
Information provided by Schering-Plough

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Chronic Hepatitis C
2 Additional conditions recognized in this trial
Hepatitis
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
3 More general conditions related to this trial
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
RNA Virus Infections
Virus Diseases
4 Interventions listed in this trial
SCH 503034
5 Additional drug interventions recognized in this trial
Peginterferon alfa-2b
Ribavirin
6 More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antiviral Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
7 Sponsors listed in this trial
Schering-Plough




Links to all studies - primarily for crawlers